Showing 1,841 - 1,860 results of 122,555 for search '(( 2 e decrease ) OR ( 5 ((teer decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.76s Refine Results
  1. 1841
  2. 1842
  3. 1843
  4. 1844
  5. 1845
  6. 1846
  7. 1847

    Retinoschisin secretion into the conditioned medium is decreased by addition of jasplakinolide. by Eiko Kitamura (349087)

    Published 2013
    “…As seen, retinoschisin secretion into the conditioned medium is decreased by 1 uM jasplakinolide. (C) Quantification of the intensity of each band in the Western blot in (B) (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020707#s4" target="_blank">MATERIALS AND METHODS</a>). …”
  8. 1848

    Reducing SIRT1 activity increases, and increasing SIRT1 expression decreases, mitochondrial enzymes in C<sub>2</sub>C<sub>12</sub> myotubes and rat skeletal muscle. by Kazuhiko Higashida (351645)

    Published 2013
    “…<p>(A) Suppression of SIRT1 activity with dominant-negative SIRT1 H355A in C<sub>2</sub>C<sub>12</sub> myotubes increases mitochondrial proteins. …”
  9. 1849
  10. 1850
  11. 1851
  12. 1852
  13. 1853

    siRNA treatment decreases ADAMTS-1 nuclear pattern in MDA-MB-231 cells. by Suély V. Silva (3233223)

    Published 2016
    “…(D-E) Aggrecan Western blot after digestion. Lane 1: Aggrecan from bovine articular cartilage (300 nM); Lane 2: Aggrecan from bovine articular cartilage (300 nM) incubated with 30 μg of MDA-MB-231 nuclear fraction; Lane 3: 30 μg of MDA-MB-231 nuclear fraction. …”
  14. 1854

    A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation. by Karin M. Hardiman (555189)

    Published 2014
    “…<p><i>CDX2P-CreER<sup>T2</sup> Apc<sup>fl/fl</sup></i> mice were injected with TAM and monitored until polyposis was seen endoscopically, then the mice were treated with vehicle or RAP at 3 mg/kg concentration for periods of one, three, or five days (N = 5 per timepoint). …”
  15. 1855
  16. 1856
  17. 1857

    Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…Shown, mean value of six technical replicates. *denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”
  18. 1858
  19. 1859
  20. 1860